Category list : Bacterial infections
Sort by: Newest first Oldest first A-Z Z-A
-
Dame Sally Davies and Keith Ridge urge review of gonorrhoea treatment protocols Subscription
GPs and internet pharmacies that provide access to online prescribing services should review their gonorrhoea treatment protocols to ensure they comply with national recommendations, say chief medical officer Dame Sally Davies and chief pharmaceutical officer Keith Ridge.
-
Janssen and Novartis pick up 2014 Prix Galien awards Subscription
Janssen and Novartis scooped prizes at the UK Prix Galien Awards for the first new drug for tuberculosis (TB) in 40 years and the first broadly protective meningitis B vaccine.
-
Clostridium difficile: diagnosis and treatment update Subscription
There are around 12,000 cases of Clostridium difficile infection (CDI) each year in the UK and during 1999 to 2007, deaths from CDI peaked at around 4,000 per year. This article summarises diagnosis and management, as well as the current therapeutic options for CDI, including faecal microbiota transplant.
-
2014: The Pharmaceutical Journal's news in review Subscription
Looking back at some of the biggest news stories from the past year.
-
40pc of NPA members in chlamydia service
The chlamydia testing service offered by the National Pharmacy Association has been well received since its launch in the summer (PJ, 16 August 2008, p183). About 40 per cent of members have already registered ahead of the service becoming fully active in November 2008.
-
7-day antibiotic course ‘non-inferior’ to 14 days for treatment of Gram-negative bacteraemia Subscription
Research has shown that shorter antibiotic courses are not inferior to longer courses for the treatment of Gram-negative bacteraemia.
-
A fragile defence: Antimicrobial resistance
Calls to tighten the control of antibiotics must be backed with action if we are to overcome the looming crisis in public health.
-
A strong base: the importance of foot health
Healthcare professionals are beginning to recognise the importance of keeping our feet in good working order, but does more need to be done to communicate this message to the public? Find out in this feature produced in partnership with RB.
-
Acid-reducing drugs could increase risk of bacterial infection in children Subscription
Acid suppression medication is associated with Clostridium difficile infection (CDI) in infants and children aged up to 17 years in an outpatient setting, researchers found in a population-based study.
-
Adding bezlotoxumab to standard treatment for C. difficile reduces recurrent infection rate
The addition of a new human monoclonal antibody called bezlotoxumab to standard antibiotic treatment for Clostridium difficile infection can reduce the risk of a repeat infection, according to new research.
